Cleared Special

K212074 - ClariCT.AI (FDA 510(k) Clearance)

Jul 2021
Decision
25d
Days
Class 2
Risk

K212074 is an FDA 510(k) clearance for the ClariCT.AI. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Claripi, Inc. (Seoul, KR). The FDA issued a Cleared decision on July 27, 2021, 25 days after receiving the submission on July 2, 2021.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K212074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2021
Decision Date July 27, 2021
Days to Decision 25 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050